Dr Brian J Dorfman, DMD, MD | |
42104 N Venture Dr, Ste A106, Anthem, AZ 85086-3824 | |
(623) 551-6556 | |
(623) 551-6557 |
Full Name | Dr Brian J Dorfman |
---|---|
Gender | Male |
Speciality | Oral & Maxillofacial Surgery |
Location | 42104 N Venture Dr, Anthem, Arizona |
Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1609871094 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
1223S0112X | Dentist - Oral And Maxillofacial Surgery | 6337 (Arizona) | Secondary |
204E00000X | Oral & Maxillofacial Surgery | 32232 (Arizona) | Primary |
Mailing Address | Practice Location Address |
---|---|
Dr Brian J Dorfman, DMD, MD 42104 N Venture Dr, Ste A106, Anthem, AZ 85086-3824 Ph: (623) 551-6556 | Dr Brian J Dorfman, DMD, MD 42104 N Venture Dr, Ste A106, Anthem, AZ 85086-3824 Ph: (623) 551-6556 |
News Archive
Researchers from the Children's Environmental Health Center at The Mount Sinai Medical Center in New York have found an association between exposure to the chemical group known as phthalates and obesity in young children - including increased body mass index (BMI) and waist circumference.
Maternal mortality has declined by more than one-third since 1990, according to a report from U.N. agencies released on Wednesday, Agence France-Presse reports. But the agencies warned that the rate of progress was too slow and that the decline still misses the maternal mortality Millennium Development Goal target of a three-quarters cut (9/15).
Transcept Pharmaceuticals, Inc. today announced that the second patent covering the composition and use of Intermezzo® (zolpidem tartrate sublingual tablet), the lead Transcept product candidate, has been issued by the United States Patent and Trademark Office.
Immunocore Limited, a world-leading biotechnology company developing novel T cell receptor (TCR) based biological drugs to treat cancer, viral infections and autoimmune disease, today announced the completion of a US $320 million (GBP £205 million) private financing round.
"Nearly a half-century after U.S. cigarette packs were emblazoned with their first, modest warning, 'Caution: Cigarette Smoking May be Hazardous to Your Health,' the Food and Drug Administration - at Congress' behest - is … requiring tobacco companies to print painful images, such as that of a man smoking through a hole in his throat or of a lip eroded by cancer and a mouthful of rotting teeth, right on their cigarette packs," the Philadelphia Inquirer reports.
› Verified 8 days ago